Thursday, December 11th, 2025: Day Three - ET (Eastern Time, GMT-05:00)
Gain actionable insights on WAC optimization strategies, pricing governance models and access-driven pricing approaches that drive both commercial success and patient affordability
Manage the gross-to-net bubble across diverse product portfolios including branded pharmaceuticals, generics and biosimilars to maximize financial performance
Understand financial reporting risks associated with complex distribution channel dynamics
- Jeffrey R. Miller, CPA, CGMA - VP Finance & Corporate Controller, Lannett Company
Gain insight on the current status of the CMS Maximum Fair Price (MFP) for the first ten drugs selected for the Medicare Drug Price Negotiation Program scheduled to go live on January 1, 2026 and how the Medicare Transaction Facilitator (MTF) data model will operate and what stakeholders can expect from upcoming regulatory changes
Hear more about latest NCPDP standards developments and the industry pledges for advancing interoperability within healthcare systems to improve data exchange and care coordination
Understand stakeholder action plans for digital therapeutics integration and opportunities for expanding clinical services in pharmacy settings to enhance patient care delivery
- Rick Sage - Executive Vice President, Innovation & Standards, National Council for Prescription Drug Programs, Inc. (NCPDP)
Explore how to maximize the potential of existing commercial structures and teams to secure assets with commercial potential
Understand how to position your company to navigate future market volatility and events, ensuring long-term growth and stability
Discover the benefits of forming strategic partnerships, joint ventures and alliances to drive growth and share risks in the pharmaceutical market
Examine the rapidly evolving digital therapeutics market, including growth projections, regulatory developments and emerging therapeutic areas showing highest adoption potential
Discover optimal distribution models for digital health products, from direct-to-provider pathways to pharmaceutical partnerships, payer integration and consumer-directed approaches
Learn effective collaboration frameworks between digital therapeutic companies and channel partners, including value creation strategies, revenue models and integration best practices